Physician profile
Kenneth Han
NPI 1811960982
$137,216.18
in general payments reported to CMS, 2019-2025
8 companies · $131K in 2025
The $131K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.88 · 2021: $2,400 · 2022: $116 · 2024: $3,914 · 2025: $131K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $134K · Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $134,340.82 |
| Food and Beverage | $279.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $130,441.82 | 2025 | |
| Butterfly Network, INC. | $3,899.00 | 2024 | |
| Glaxosmithkline, LLC. | $2,505.86 | 2021-2025 | Shingrix, Bexsero, Penmenvy |
| Bolton Medical INC | $158.61 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Amgen INC. | $115.88 | 2022 | |
| Tulsa Dental Products LLC | $40.82 | 2019 | |
| Merck Sharp & Dohme LLC | $39.06 | 2019 | |
| Organon LLC | $15.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.